Evidence map›Paper›PMID 19332486›Full record

ArticleThe Journal of physiology2009

Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats.

Eduardo R Ropelle, José R Pauli, Patrícia Prada, Dennys E Cintra, Guilherme Z Rocha, Juliana C Moraes, Marisa J S Frederico, Gabrielle da Luz, Ricardo A Pinho, José B C Carvalheira and 3 more

RetractedOpen access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 64 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. A Review ofCells · 2020
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. JAK-STAT and feeding.JAK-STAT · 2013
    Review
  18. Article
  19. Article
  20. Specific down regulation of 3T3-L1 adipocyte differentiation by cell-permeable antisense HIF1alpha-oligonucleotide.Journal of controlled release : official journal of the Controlled Release Society · 2010
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Eduardo R RopelleDepartamento de Clínica Médica, FCM, Universidade Estadual de Campinas, Campinas, SP, Brazil.
José R Pauli
Patrícia Prada
Dennys E Cintra
Guilherme Z Rocha
Juliana C Moraes
Marisa J S Frederico
Gabrielle da Luz
Ricardo A Pinho
José B C Carvalheira
Licio A Velloso
Mario A Saad
Cláudio T De Souza
Universidade Estadual de Campinas (UNICAMP) · BRUniversidade do Extremo Sul Catarinense · BRUniversidade Federal de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Insulin signalling in the hypothalamus plays a role in maintaining body weight. The forkhead transcription factor Foxo1 is an important mediator of insulin signalling in the hypothalamus. Foxo1 stimulates the transcription of the orexigenic neuropeptide Y and Agouti-related protein through the phosphatidylinositol-3-kinase/Akt signalling pathway, but the role of hypothalamic Foxo1 in insulin resistance and obesity remains unclear. Here, we identify that a high-fat diet impaired insulin-induced hypothalamic Foxo1 phosphorylation and degradation, increasing the nuclear Foxo1 activity and hyperphagic response in rats. Thus, we investigated the effects of the intracerebroventricular (i.c.v.) microinfusion of Foxo1-antisense oligonucleotide (Foxo1-ASO) and evaluated the food consumption and weight gain in normal and diet-induced obese (DIO) rats. Three days of Foxo1-ASO microinfusion reduced the hypothalamic Foxo1 expression by about 85%. i.c.v. infusion of Foxo1-ASO reduced the cumulative food intake (21%), body weight change (28%), epididymal fat pad weight (22%) and fasting serum insulin levels (19%) and increased the insulin sensitivity (34%) in DIO but not in control animals. Collectively, these data showed that the Foxo1-ASO treatment blocked the orexigenic effects of Foxo1 and prevented the hyperphagic response in obese rats. Thus, pharmacological manipulation of Foxo1 may be used to prevent or treat obesity.

Indexed as

Adipose Tissue, WhiteAnimalsBlood GlucoseBody WeightCell NucleusDietEatingEnergy IntakeEpididymisForkhead Box Protein O1Forkhead Transcription FactorsGene ExpressionHypothalamusInsulinInsulin Receptor Substrate ProteinsMaleBlood GlucoseForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, ratInsulinInsulin Receptor Substrate ProteinsIrs2 protein, ratNerve Tissue ProteinsOligonucleotides, Antisensep300-CBP Transcription FactorsProto-Oncogene Proteins c-aktReceptor, Insulin

Identifiers

PMID19332486
PMCPMC2697302
OpenAlexW2102389575

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.